Guardian Pharmacy Services, Inc.

GRDN · NYSE · Stock · Healthcare
$40.58
+1.93% today
Delayed price,

What Guardian Pharmacy Services does

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.

Key facts

Sector
Healthcare
Industry
Medical Care Facilities
Market cap
$2.57B
P/E (ttm)
39.4
Forward P/E
28.3
Dividend yield
0.00%
Beta
0.02
Profit margin
4.5%
Employees
3,600
Headquarters
Atlanta, GA, United States
Exchange
NYSE

Performance

1 Month
-9.8%
3 Months
+0.1%
6 Months
+8.1%
1 Year
+62.6%
5 Years
+126.6%
$23.3752-week range$48.33
Biggest setback — last 12 months
-15.4%
3 Aug 2026 → 24 Aug 2026
Fell from $43.83 to $37.06 — its sharpest sustained decline this year.
Biggest run-up — last 12 months
+80.3%
13 Oct 2025 → 14 Sept 2026
Ran from $24.95 to $44.99 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Above long-term trend
Price sits above its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.
HorizonBear case (−1σ)Base caseBull case (+1σ)
1 Month$35.36 (-11.2%)$39.81$44.82 (+12.6%)
3 Months$32.42 (-18.6%)$39.81$48.89 (+22.8%)
6 Months$29.77 (-25.2%)$39.81$53.23 (+33.7%)
12 Months$26.40 (-33.7%)$39.81$60.04 (+50.8%)
Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 41.1%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

Recent headlines

Recent insider activity

Acquired 38,282 shares — Mudd William Franklin, See Remarks · 2026-09-28
Acquired 23,450 shares — Weir Robert, See Remarks · 2026-09-28
Acquired 1,884,996 shares — Ackerman John, Director · 2026-09-28
Acquired 6,100,175 shares — Salentine Thomas J Jr, Director · 2026-09-28
Acquired 39,865 shares — Martin David Norman, See Remarks · 2026-09-28
Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.